[u'-----BEGIN PRIVACY-ENHANCED MESSAGE-----\nProc-Type: 2001,MIC-CLEAR\nOriginator-Name: webmaster@www.sec.gov\nOriginator-Key-Asymmetric:\n MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen\n TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB\nMIC-Info: RSA-MD5,RSA,\n M9biPfKRbS+DVe+hhpzMnhh8naXDZ61e/6QAXovoggI/A2FpiMvKCXr8Wtn8iQB1\n oq5k3sEaMKl+yJBKidc4sA==\n\n', u'0001144204-04-013947.txt : 20040907\n', u'0001144204-04-013947.hdr.sgml : 20040906\n', u'20040907162208\nACCESSION NUMBER:\t\t0001144204-04-013947\nCONFORMED SUBMISSION TYPE:\t8-K\nPUBLIC DOCUMENT COUNT:\t\t3\nCONFORMED PERIOD OF REPORT:\t20040903\nITEM INFORMATION:\t\tResults of Operations and Financial Condition\nITEM INFORMATION:\t\tFinancial Statements and Exhibits\nFILED AS OF DATE:\t\t20040907\nDATE AS OF CHANGE:\t\t20040907\n\nFILER:\n\n\tCOMPANY DATA:\t\n\t\tCOMPANY CONFORMED NAME:\t\t\tPRECISION OPTICS CORPORATION INC\n\t\tCENTRAL INDEX KEY:\t\t\t0000867840\n\t\tSTANDARD INDUSTRIAL CLASSIFICATION:\tELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]\n\t\tIRS NUMBER:\t\t\t\t042795294\n\t\tSTATE OF INCORPORATION:\t\t\tMA\n\t\tFISCAL YEAR END:\t\t\t0630\n\n\tFILING VALUES:\n\t\tFORM TYPE:\t\t8-K\n\t\tSEC ACT:\t\t1934 Act\n\t\tSEC FILE NUMBER:\t001-10647\n\t\tFILM NUMBER:\t\t041018885\n\n\tBUSINESS ADDRESS:\t\n\t\tSTREET 1:\t\t22 EAST BROADWAY\n\t\tCITY:\t\t\tGARDNER\n\t\tSTATE:\t\t\tMA\n\t\tZIP:\t\t\t01440-3338\n\t\tBUSINESS PHONE:\t\t9786301800\n\n\tFORMER COMPANY:\t\n\t\tFORMER CONFORMED NAME:\tPRECISION OPTICS CORP INC\n\t\tDATE OF NAME CHANGE:\t19600201\n', u'\n', u'\n', u'8-K\n', u'1\n', u'v06552_8k.htm\n', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'UNITED STATES ', u'\n', u'SECURITIES AND EXCHANGE COMMISSION', u'\n', u'WASHINGTON, D.C. 20549 ', u'\n', u'_______________________ ', u'\n', u'\n      FORM 8-K ', u'\n', u'\n', u'CURRENT REPORT ', u'\n', u'PURSUANT TO SECTION 13 OR 15(D) OF THE', u'\n', u'THE SECURITIES EXCHANGE ACT OF 1934 ', u'\n', u'\n', u'\n', u'\n', u'\n', u'Date of report (Date of earliest event reported):', u'\n', u'\n', u'\n', u'\n', u'September 3, 2004', u'\n', u'\n', u'\n', u'\n', u' ', u'PRECISION\n      OPTICS CORPORATION, INC.', u'\n', u'\n', u'.', u'(Exact name\n      of registrant as specified in its charter)', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'Massachusetts', u'\xa0\n    ', u'\n', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\n', u'001-10647', u'\xa0 ', u'\n', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\n', u' ', u'04-2795294', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\n', u'\n', u' ', u'(State or other jurisdiction of', u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u'(Commission', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'(I.R.S. Employer', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'of incorporation or organization)', u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u'File Number)', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'Identification No.)', u'\xa0 ', u'\n', u'\n', u'\n', u'\n', u'\n', u' ', u'22 East Broadway, Gardner, Massachusetts\xa0\xa0\xa0\xa0\n      01440', u'\n', u'\n', u'(Address of Principal Executive Offices)\xa0\xa0\xa0\xa0\n      (Zip Code)', u'\n', u'\n', u'\n', u'\n', u'Registrant\x92s telephone number, including area code: (978) 630-1800', u'\n', u'\n\xa0\xa0\xa0\xa0\xa0', u'Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (', u'see ', u'General Instruction A.2. below): ', u'\n', u'\n', u'\n', u' ', u'|_|\xa0 ', u'\xa0\n    ', u'\n', u' ', u'Written communications pursuant\n      to Rule 425 under the Securities Act (17 CFR 230.425)', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'|_|\xa0 ', u'\xa0\n    ', u'\n', u' ', u'Soliciting material pursuant\n      to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'|_|\xa0 ', u'\xa0\n    ', u'\n', u' ', u'Pre-commencement communications\n      pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR', u' ', u'240.14d-2(b))', u'\n', u'\n', u'\n', u' ', u'|_|\xa0 ', u'\xa0\n    ', u'\n', u'Pre-commencement communications\n      pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))\n      ', u'\n', u'\n', u'\n', u'\n', u' ', u' ', u' ', u'\n', u'\n', u'\n', u'\n', u' ', u'Item 2.02. \xa0\xa0\xa0\xa0\xa0Results\n  of Operations and Financial Condition.', u'\n', u'\n\xa0\xa0\xa0\xa0\xa0', u'On September 3, 2004, the Registrant issued the press release attached as Exhibit 99.1 announcing operating results on an unaudited basis for the fourth quarter of fiscal year 2004 and for the\nfiscal year ended June 30, 2004. The information in this Form 8-K and the Exhibit attached hereto shall not be deemed \x93filed\x94 for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by\nreference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.', u'\n', u'\n', u'\n', u' ', u'Item 9.01.', u'\xa0\xa0\xa0\xa0\xa0', u'Financial\n      Statements and Exhibits.', u'\xa0 \xa0\xa0\xa0\xa0\xa0\xa0', u'\n', u'\n', u'\n', u'\xa0\xa0\xa0\xa0\xa0', u'\n', u' ', u'(c)', u'\xa0 ', u'\n', u'\xa0\xa0\xa0\xa0\xa0\xa0', u'\n', u' ', u'Exhibit Number', u'\xa0\n    ', u'\n', u'\xa0\xa0\xa0\xa0\xa0', u'\n', u' ', u'Title', u'\xa0\n    ', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0 ', u'\n', u'\xa0', u'\n', u' ', u'99.1', u'\xa0 ', u'\n', u'\xa0', u'\n', u' ', u'Press Release issued by Precision\n      Optics Corporation, Inc. on', u'\xa0 ', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0 ', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'September 3, 2004.', u' ', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'SIGNATURE', u'\n', u'\n', u'\n\xa0\xa0\xa0\xa0\xa0', u'Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n', u'\n', u'\n', u'\n', u'\xa0 ', u'\n', u' ', u'PRECISION OPTICS\n      CORPORATION, INC.', u'\xa0 ', u'\n', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'Date: September 7, 2004', u'\xa0\n    ', u'\n', u' ', u'By:', u'\xa0\n    ', u'\n', u' \xa0 \xa0', u'/s/\n      Jack P. Dreimiller', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'\n', u' ', u'\n', u' ', u' ', u'\n', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' \xa0 \xa0', u'Name:', u'\xa0\n    ', u'\n', u' ', u'Jack P. Dreimiller', u'\xa0\n    ', u'\n', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' \xa0 \xa0', u'Title:', u'\xa0\n    ', u'\n', u' ', u'Senior Vice President, Finance\n      and', u'\xa0 ', u'\n', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'Chief Financial Officer', u'\xa0\n    ', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'EXHIBIT INDEX', u'\n', u'\n', u'\n', u'\n', u'\n', u'Exhibit Number', u'\xa0\n\t', u'\n', u'\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\n', u' ', u'Description', u'\xa0\n    ', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'99.1', u'\xa0\n\t', u'\n', u'\xa0\n\t', u'\n', u' ', u'Press Release issued\n      by Precision Optics Corporation, Inc. on September 3, 2004.', u'\xa0\n    ', u'\n', u'\n', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'EX-99.1\n', u'2\n', u'v06552_ex99-1.htm\n', u'\n', u'\n', u'Exhibit 99.1', u'\n', u' ', u'\n', u'\n', u'\n', u'\n', u'\xa0\xa0\xa0\xa0\xa0\xa0', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0', u'\n', u' ', u'PRECISION\n      OPTICS CORPORATION', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'22\n      EAST BROADWAY', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'GARDNER,\n      MASSACHUSETTS 01440-3338', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'Telephone\n      978 / 630-1800', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'Telefax\n      978 / 630-1487', u'\xa0 ', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u' \xa0', u'POC:24-0346', u'\xa0\n    ', u'\n', u'\n', u'\n', u'\xa0', u'\n', u' \xa0', u'Page\n      1 of 4', u'\xa0 ', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'NEWS\n      RELEASE', u'\xa0 ', u' ', u' ', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'FOR IMMEDIATE\n      RELEASE', u'\n', u'Friday,\n      September 3, 2004', u'\xa0 ', u'\n', u'\n', u'\n', u'PRECISION OPTICS\n  CORPORATION ANNOUNCES ', u'\n  FOURTH QUARTER AND YEAR END RESULTS', u' ', u'\n', u' ', u'GARDNER, Massachusetts', u'\n  -', u' Precision Optics\n  Corporation, Inc. (Nasdaq: POCI) today announced operating results on an unaudited\n  basis for the fourth quarter of fiscal year 2004 ended June 30, 2004. ', u'\n', u' ', u'Fourth Quarter Operating\n  Results', u'\n', u'\n', u' ', u'Revenues', u'\n  \x96 For the quarter ended June 30, 2004, revenues were $285,576 compared\n  to $363,947 for the same period last year, a decrease of 21.5% . Revenues in\n  the quarter decreased 9.0% from the preceding quarter ended March 31, 2004.\n  ', u'\n', u' ', u'Net Loss', u'\n  \x96 For the quarter ended June 30, 2004, net loss was $1,011,525, or $0.58\n  per share, an increase of $3,353, from the net loss of $1,008,172, or $0.58\n  per share, for the same period last year. The weighted average common shares\n  outstanding were 1,752,053 during both periods. ', u'\n', u' ', u'Special Charges', u'\n  \x96 Net loss for the quarter ended June 30, 2004 included provisions for\n  obsolete and slow moving inventories of $191,200. Net loss for the quarter ended\n  June 30, 2003 included a provision for asset impairment of $123,511.', u'\n', u' ', u'Fiscal Year 2004 Operating\n  Results', u'\n', u'\n', u' ', u'Revenues', u'\n  \x96 For the year ended June 30, 2004, revenues were $1,464,964 compared to\n  $2,399,217 for the same period last year, a decrease of 38.9% .', u'\n', u' ', u'Net Loss', u'\n  \x96 For the year ended June 30, 2004, net loss was $3,684,076, or $2.10 per\n  share, an increase of $756,314 compared to the net loss of $2,927,762, or $1.67\n  per share, for the year ended June 30, 2003. The weighted average common shares\n  outstanding were 1,752,053 during both periods.', u'\n', u' ', u'Special Charges', u'\n  \x96 Net loss for the year ended June 30, 2004 and 2003 included provisions\n  for asset impairment and restructuring of $52,208 and $176,642, respectively.\n  Net loss for the year ended June 30, 2004 included provisions for obsolete and\n  slow-moving inventories of $500,000.', u'\n', u' ', u'Cash Flow and Expenditures', u'\n', u'\n', u' ', u'For the quarter ended June\n  30, 2004, cash and cash equivalents decreased by approximately $602,000 compared\n  to a decrease of approximately $781,000 for the previous quarter ended March\n  31, 2004. Cash disbursements during the quarter ended March 31, 2004 included\n  approximately $52,000 paid for employee severance costs.', u'\n', u' ', u'Capital equipment expenditures\n  during the year ended June 30, 2004 were approximately $33,600, up 21% from\n  the same period in 2003. Future capital expenditures will depend on future sales\n  and the success of ongoing research and development efforts. ', u'\n', u' ', u'For the quarter ended June\n  30, 2004, research and development expenses were approximately $339,000, up\n  2% from $333,000 for the quarter ended June 30, 2003. Quarterly research and\n  development expenses depend on the Company\x92s assessment of new product\n  opportunities.', u'\n', u'\n', u'\n', u'\n', u'\n', u'Precision\n      Optics Corporation\x97Fourth Quarter and Year End Results', u'\n', u' ', u'Page\n      2 of 4', u'\n', u'\n', u'\n', u'\n', u' ', u'Successful Completion\n  of Rights Offering', u'\n', u'\n', u' ', u'As previously announced,\n  in July 2004, the Company completed a rights offering to stockholders. Stockholders\n  exercised subscription rights to purchase the entire 5,256,159 shares of common\n  stock offered at a subscription price of $1.00 per share, raising gross proceeds\n  of $5,256,159. ', u'\n', u' ', u'There were 1,324,666 shares\n  purchased through the exercise of basic subscription rights and an additional\n  3,931,493 shares purchased through the over subscription privilege. The Company\n  received subscriptions for a total of 7,554,093 shares, exceeding the total\n  number of shares offered by 2,297,934 shares, or 43.7% . ', u'\n', u' ', u'Customer Relationships', u'\n', u'\n', u' ', u'The Company is in discussions\n  with several customers regarding manufacturing of prototypes of advanced endoscopes\n  incorporating ultra-small lenses, ranging in size from .5 mm to 1 mm, which\n  include utilization of the Company\x92s patent-pending micro-precision', u'TM', u'\n  lens technology. These initiatives encompass a variety of innovative techniques\n  involving minimally invasive surgery. ', u'\n', u' ', u'Expense Reduction', u'\n', u'\n', u' ', u'As previously announced,\n  the Company has taken additional measures to realign its cost structure with\n  current revenue expectations. In January 2004, the Company reduced its workforce\n  by five full-time employees, a 15% reduction. As a result of this action, the\n  Company recorded a non-recurring pretax charge to earnings of $52,208 for employee\n  severance benefits in the quarter ended March 31, 2004. In addition, the Company\n  is in the process of reviewing other expense areas to determine where additional\n  reductions in discretionary spending can be achieved. ', u'\n', u' ', u'Outlook', u'\n', u'\n', u' ', u'The Company expects its\n  recent pattern of quarter-to-quarter revenue fluctuations to continue, due to\n  the uncertain timing of orders from customers and their size in relation to\n  total revenues. The Company continues to move forward with new products and\n  technical innovations, in particular, the development of a new generation (patent\n  pending) of its world-class product line of 3-D endoscopes, the development\n  of a new prototype 2.7 mm endoscope, and new instruments utilizing the Company\x92s\n  new micro-precision', u'TM', u'\n  lens technology (patent pending) for endoscopes under 1 mm. The Company continues\n  to explore potential applications of single-molecule technology and nanotechnology.\n  ', u'\n', u'\n', u'\n', u' ', u'About\n      Precision Optics', u' ', u'\n', u'\n', u'\n', u' ', u'Precision Optics Corporation,\n  a leading developer and manufacturer of advanced optical instruments since 1982,\n  designs and produces high-quality optical thin film coatings, medical instruments,\n  and other advanced optical systems. The Company\x92s medical instrumentation\n  line includes laparoscopes, arthroscopes and endocouplers and a world-class\n  product line of 3-D endoscopes for use in minimally invasive surgical procedures.', u'\n', u' ', u'The Company is currently\n  developing specialty instruments incorporating its patent-pending LENSLOCK', u'TM', u'\n  technology which ensures lower cost, easier repairability and enhanced durability\n  as well as ultra-small instruments (some with lenses less than one millimeter\n  in diameter) utilizing patent-pending micro-precision', u'TM', u' lens technology.\n  The Company is also exploring new initiatives in single-molecule technology\n  and nanotechnology for biomedical and other applications.', u'\n', u' ', u'Precision Optics Corporation\n  is certified to the ISO 9001 Quality Standard, and complies with the FDA Good\n  Manufacturing Practices and the European Union Medical Device Directive for\n  CE Marking of its medical products. The Company\x92s Internet Website is www.poci.com.', u'\n', u'\n', u'\n', u'\n', u'\n', u'Precision\n      Optics Corporation\x97Fourth Quarter and Year End Results', u'\n', u' ', u'Page\n      3 of 4', u'\n', u'\n', u'\n', u' ', u'PRECISION OPTICS\n  CORPORATION, INC. AND SUBSIDIARIES ', u'\n  CONSOLIDATED STATEMENTS OF OPERATIONS ', u'\n', u'FOR THE THREE AND TWELVE\n  MONTHS ENDED ', u'\n  June 30, 2004 AND 2003 ', u'\n', u'(UNAUDITED) ', u'\n', u'\n', u'\n', u'\n', u'\xa0 ', u'\n', u' ', u'--\n      THREE MONTHS --', u' ', u'\n', u'\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\n', u' ', u'--TWELVE\n      MONTHS--', u' ', u'\n', u'\n', u'\n', u'\xa0 ', u'\n', u' ', u'2004', u'\n', u'\xa0\xa0\xa0\xa0\xa0\xa0', u'\n', u'2003', u'\n', u'\xa0', u'\n', u' ', u'2004', u'\n', u'\xa0\xa0\xa0\xa0\xa0\xa0', u'\n', u' ', u'2003', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u' ', u'REVENUES', u'\xa0\n    ', u'\n', u' ', u'$', u'\n', u'\n', u' ', u'285,576', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0', u'\n', u' ', u'$', u'\n', u'\n', u' ', u'363,947', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'$', u'\n', u'\n', u' ', u'1,464,964', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'$', u'\xa0\n    ', u'\n', u' ', u'2,399,217', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'COST\n      OF GOODS SOLD', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'547,936', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0', u'\n', u'\xa0 ', u'\n', u' ', u'465,052', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'2,062,902', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'2,072,238', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'\xa0\xa0\xa0\xa0\xa0\xa0Gross\n      Profit (Loss)', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'(', u'262,360', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\xa0', u'\n', u'\xa0 ', u'\n', u' ', u'(101,105', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'(\n      597,938', u' ', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'326,979', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'RESEARCH\n      and DEVELOPMENT', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'338,651', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0', u'\n', u'\xa0 ', u'\n', u' ', u'332,610', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'1,319,345', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'1,235,252', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'SELLING,\n      GENERAL and', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'ADMINISTRATIVE\n      EXPENSES', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'411,389', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0', u'\n', u'\xa0 ', u'\n', u' ', u'460,929', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'1,731,713', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'1,881,313', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'PROVISION\n      FOR IMPAIRMENT AND', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\x97', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0', u'\n', u'\xa0 ', u'\n', u' ', u'123,511', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'52,208', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'176,642', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'RESTRUCTURING', u'\xa0\n    ', u'\n', u' ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'LOSS\n      ON SALE OF ASSETS HELD', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'FOR\n      SALE', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\x97', u'\n', u'\xa0 ', u'\n', u'\xa0', u'\n', u'\xa0 ', u'\n', u' ', u'\x97', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\x97', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'19,171', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u' ', u'\xa0\xa0\xa0\xa0\xa0\xa0Total\n      Operating Expenses', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'750,040', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0', u'\n', u'\xa0 ', u'\n', u' ', u'917,050', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'3,103,266', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'3,312,378', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' \xa0\xa0\xa0\xa0\xa0', u'Operating\n      Loss', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'(1,012,400', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\xa0', u'\n', u'\xa0 ', u'\n', u' ', u'(1,018,155', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'(3,701,204', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'(2,985,399', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'INTEREST\n      INCOME', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'1,787', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0', u'\n', u'\xa0 ', u'\n', u' ', u'11,020', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'18,089', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'65,443', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'INTEREST\n      EXPENSE', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\x97', u'\n', u'\xa0 ', u'\n', u'\xa0', u'\n', u'\xa0 ', u'\n', u' ', u'(125', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'(49', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'(6,894', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u' ', u'LOSS\n      BEFORE PROVISION FOR', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'INCOME\n      TAXES', u'\xa0 ', u'\n', u' ', u'$', u'\n', u'\n', u' ', u'(1,010,613', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\xa0', u'\n', u'$', u'\n', u'(1,007,260', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u' ', u'$', u'\n', u'\n', u' ', u'(3,683,164', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u'$', u'\xa0\n    ', u'\n', u'(2,926,850', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\n', u'\n', u' ', u'PROVISION\n      FOR INCOME TAXES', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'912', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0', u'\n', u'\xa0 ', u'\n', u' ', u'912', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'912', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'912', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u' ', u'NET\n      LOSS', u'\xa0 ', u'\n', u' ', u'$', u'\n', u'\n', u' ', u'(', u'1,011,525', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\xa0', u'\n', u'$', u'\n', u'\n', u'(1,008,172', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u' ', u'$', u'\n', u'\n', u' ', u'(3,684,076', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u' ', u'$\xa0', u'\n', u'\n', u'(2,927,762', u'\n', u')', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u' ', u'Basic\n      and Diluted Loss Per Share', u'\xa0 ', u'\n', u' ', u'$', u'\n', u'\n', u' ', u'(0.58', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\xa0', u'\n', u' ', u'$', u'\n', u' ', u'(0.58', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u' ', u'$', u'\n', u'\n', u' ', u'(\n      2.10', u' ', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u' ', u'$', u'\xa0\n    ', u'\n', u' ', u'(1.67', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u' ', u'Weighted\n      Average Common Shares', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' \xa0 \xa0', u'Outstanding', u'\xa0\n    ', u'\n', u' ', u'\n', u' ', u'1,752,053', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0', u'\n', u'\xa0 ', u'\n', u' ', u'1,752,053', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'1,752,053', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'1,752,053', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'Precision\n      Optics Corporation\x97Fourth Quarter and Year End Results', u'\n', u' ', u'Page\n      4 of 4', u'\n', u'\n', u'\n', u'PRECISION OPTICS\n  CORPORATION, INC. AND SUBSIDIARIES ', u'\n  CONSOLIDATED BALANCE SHEETS ', u'\n  (UNAUDITED)', u'\xa0 ', u'\n', u'\n', u'\n', u'\n', u'\n', u'ASSETS', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0 ', u'\n', u' ', u'June\n      30, 2004', u' ', u'\n', u'\xa0 ', u'\n', u' ', u'June\n      30, 2003', u' ', u'\n', u'\n', u'\n', u' ', u'\n', u' ', u'\n', u' ', u' ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u'\n', u'\n', u' ', u'CURRENT\n      ASSETS', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\n      \xa0 \xa0', u'Cash and Cash Equivalents', u'\xa0\n    ', u'\n', u' ', u'$', u'\xa0\n    ', u'\n', u' ', u'343,260', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'$', u'\xa0\n    ', u'\n', u' ', u'3,504,414', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\n      \xa0 \xa0', u'Accounts Receivable,\n      Net', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'80,195', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'191,669', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\n      \xa0 \xa0', u'Inventories', u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u' ', u'917,998', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'1,257,288', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\n      \xa0 \xa0', u'Prepaid Expenses', u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u' ', u'80,646', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'91,213', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\n      \xa0 \xa0', u'Deferred Financing\n      Costs', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'171,885', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\x97', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\n      \xa0 \xa0', u'Assets Held for\n      Sale', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\xa0\n      ', u'\x97', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'152,550', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'\n', u' ', u'\n', u' ', u' ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u'\n', u'\n', u' \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\n      \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\n      \xa0', u'Total Current Assets', u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u' ', u'1,593,984', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'5,197,134', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'PROPERTY\n      AND EQUIPMENT', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'4,199,835', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'4,013,680', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\n      \xa0 \xa0', u'Less: Accumulated\n      Depreciation', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'(3,920,593', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'(3,723,350', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\n', u'\n', u' ', u'\n', u' ', u'\n', u' ', u' ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u'\n', u'\n', u' ', u'\xa0 \xa0\n      \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0', u'\xa0\n      \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0', u'Net\n      Property and Equipment', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'279,242', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'290,330', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'\n', u' ', u'\n', u' ', u' ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u'\n', u'\n', u' ', u'OTHER ASSETS', u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u' ', u'224,088', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'236,156', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'\n', u' ', u'\n', u' ', u' ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u'\n', u'\n', u' ', u'TOTAL ASSETS', u'\xa0\n    ', u'\n', u' ', u'$', u'\xa0\n    ', u'\n', u' ', u'2,097,314', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'$', u'\xa0\n    ', u'\n', u' ', u'5,723,620', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'\n', u' ', u'\n', u' ', u' ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u"LIABILITIES\n      AND STOCKHOLDERS' EQUITY", u'\xa0 ', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u' ', u'TOTAL CURRENT\n      LIABILITIES', u'\xa0 ', u'\n', u' ', u'$', u'\xa0\n    ', u'\n', u' ', u'593,342', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'$', u'\xa0\n    ', u'\n', u' ', u'534,017', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'\n', u' ', u'\n', u' ', u' ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u'\n', u'\n', u' ', u'OTHER', u'\xa0\n    ', u'\n', u' ', u'$', u'\xa0\n    ', u'\n', u' ', u'\x97', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'$', u'\xa0\n    ', u'\n', u' ', u'1,555', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'\n', u' ', u'\n', u' ', u' ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u'\n', u'\n', u' ', u"STOCKHOLDERS'\n      EQUITY", u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\n      \xa0 \xa0', u'Common Stock, $.01\n      par value-', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'\xa0 \xa0\n      \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\n      \xa0 \xa0Authorized -- 20,000,000 shares', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\n      \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0', u'Issued\n      and Outstanding \x96 1,752,053 shares', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\n      \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0', u'at\n      June 30, 2004 and 2003', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'17,521', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'17,521', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\n      \xa0 \xa0', u'Additional Paid-in\n      Capital', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'27,770,175', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'27,770,175', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\n      \xa0 \xa0', u'Accumulated Deficit', u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u' ', u'(26,283,724', u'\n', u'\n', u')', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u' ', u'(22,599,648', u'\n', u'\n', u' ', u')', u'\xa0\n    ', u'\n', u'\n', u'\n', u' ', u'\n', u' ', u'\n', u' ', u' ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u'\n', u'\n', u' \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\n      \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\n      \xa0', u"Total Stockholders' Equity", u'\xa0\n    ', u'\n', u'\xa0 ', u'\n', u' ', u'1,503,972', u'\n', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'5,188,048', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'\n', u' ', u'\n', u' ', u' ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u"TOTAL\n      LIABILITIES AND STOCKHOLDERS'", u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' \xa0 \xa0', u'EQUITY', u'\xa0\n    ', u'\n', u'$', u'\n', u'\n', u' ', u'2,097,314', u'\n', u'\xa0 ', u'\n', u'\xa0 ', u'\n', u' ', u'$', u'\xa0\n    ', u'\n', u' ', u'5,723,620', u'\n', u'\n', u'\xa0 ', u'\n', u'\n', u'\n', u' ', u'\n', u' ', u'\n', u' ', u' ', u'\n', u'\xa0 ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u' ', u'\n', u'\n', u'\n', u'\n', u' ', u'Forward-looking statements\n  contained in this news release, including those related to the Company\x92s\n  products under development and revenue estimates, are made under "safe harbor"\n  provisions of the Private Securities Litigation Reform Act of 1995 and involve\n  a number of risks and uncertainties that could materially affect future results.\n  These risks and uncertainties, many of which are not within the Company\x92s\n  control, include, but are not limited to, the uncertainty and timing of the\n  successful development of the Company\x92s new products; the risks associated\n  with reliance on a few key customers; the Company\x92s ability to maintain\n  compliance with requirements for continued listing on the NASDAQ SmallCap Market;\n  the Company\x92s ability to attract and retain personnel with the necessary\n  scientific and technical skills, the timing and completion of significant orders;\n  the timing and amount of the Company\x92s research and development expenditures;\n  the timing and level of market acceptance of customers\x92 products for which\n  the Company supplies components; performance of the Company\x92s vendors;\n  the ability of the Company to control costs associated with performance under\n  fixed price contracts; and the continued availability to the Company of essential\n  supplies, materials and services; and the other risk factors and cautionary\n  statements listed from time to time in the Company\'s periodic reports filed\n  with the Securities and Exchange Commission, including but not limited to, the\n  Company\'s Annual Report on Form 10-KSB for the year ended June 30, 2003.', u'\n', u'\n', u'\n', u'\n', u' ', u'###', u' ', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'GRAPHIC\n', u'3\n', u'v06552x5x1.jpg\n', u'GRAPHIC\n', u'\nbegin 644 v06552x5x1.jpg\nM_]C_X``02D9)1@`!`0```0`!``#_VP!#`!`+#`X,"A`.#0X2$1`3&"@:&!86\nM$C)1TH.C,]/#DS.#=`2%Q.0$1713', u'7!D>%QE9V/_\nMVP!#`1$2$A@5&"\\:&B]C0CA"8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C\nM8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V/_P``1"`!7`0@#`2(``A$!`Q$!_\\0`\nM\'P```04!`0$!`0$```````````$"`P0%!@7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&\nMQ\\C)RM+3U-76U]C9VN\'BX^3EYN?HZ>KQ\\O/T]?;W^/GZ_\\0`\'P$``P$!`0$!\nM`0$!`0````````$"`P0%!@\'EZ@H.$\nMA8:\'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q;GZ.GJ\\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#T"BBB@`HH\nMKD[OX@:1#$6@6::0\'A-A7/XF@#K**XBV\\>2:GJ5I9V-FL332;6:8[@![8Q4G\nMB+QW\'IUT]II\\27$L9`>1C\\@/F7[6>NZ>L;AE^:$G`4]3SG/\nMX4`=M14=O/%', u'-QN5E.014E`!1110`44E', u'.=J+\'\nMRNX].>_..*`.GHKB[OQ)XCTVUAO=0TJW6U9AO"EMZ@^O/!^M=\'HFL6VMV"W5\nMLF/SKMO[5T[_`)_[\nM7_O\\O^->5>-=374O$,[12,\\,/[M,D$:`(?"T-W=:D;6P81SS(5,V[\nM!C3^+%>DVOA#1K6Q:W%G%(S#F65`S9QC()Z>N*Q/AU:PV.DSZE=,L(G?8DDC\nM@*5\'\\N', u"38Q&.%)`W'L!7D", u'X,OB$1\nM"7>D40`4\'(4GK_2@#7^&%^62[L&+G;B5', u'A->@_P!JZ=_S_P!K_P!_E_QH`N453_M73O\\`G_M?^_R_XU5U\nM37["RTVXN([N"5XT)5(Y%8D]N,T`', u'6AU>=?F8%(59.0.[`G\\N/>N#R]]?`NZJ\\\\G+,:79\nMV4-O\'>V:K&@7"S+C^=`\')?%&2X_T&+:?LW+$[>-_U^G:F?"ZWD\\Z^N=O[HJL\nM>', u'WTQ"EM).', u']M;9PMQ', u'\';>"2>;3X4CC4L[$MP\nM!R3UKQ[&6P.YXKUWQW>FS\\,7(241R38B4,"?F\'Y9KS\'0((KK7;&"==\\4DR\nMJRYQD9H`]7T[1;5O#5EI]Y:*46)&DB8GA\\9;]2:S/\'MW\'IOAE;*\'8OG$1*A!\nM^X.N/IQ75.RHA9R%4#))[5Y)XCU&X\\4>(1%:)N1#Y,"*20P!/S?C_+%`$\'A#\nM1AK6MI#*N;>,>9+SC(\'0?B2/PS7I/_"):#_T#8OS;_&G>%]#70=+$!8/-(=\\\nMKX\'7T\'L/\\:V:`,3_`(1+0?\\`H&Q?FW^-\'_"):#_T#8OS;_&MNB@#PO688[?6\nMKZ&)0D@?_`-#:@#3M+.RT>SD6VB6WMUS(P&B_$+6ULM,_LZ&0?:;G&X#.5C]>/4@#Z9K\nMF?!7AF35;R.]N`5LX\'#', u'?YQN)^5>P[\nM5M?\\(EH/_0-B_-O\\:V@,#`Z4M`&)_P`(EH/_`$#8OS;_`!KG/\'6@Z7INA+/9\nM6:0RF=5W*3TP??VKOJY[QSI\\NH^\')4@R7A82[0,EL9&/U_2@#S?PG:07WB2S\nMMKJ,20N6W(>A^4FO3O\\`A$M!_P"@;%^;?XUY+I=])IFI07D60\\+YQZCH1SZC\nM(KUB/Q?HCV8N&O8U.SU7/$4:P^-O#\nM\\29VH%498DXW>IY-`$OC+4=*M-8MHM2T@7A:$$2^805&3P!WY]^]4]/&ARW\\\nM%GJ7AK[!)!T\'XUGV/]@/J$5CJGAS^SYYR!%N\nMD+JV>F3QCG`[]:M:Z?*^(>DRW?%H4PAD^YNPW3WR5_2NGO;C2X[NV2]:W%P[\nM#R!(`6SD?=_\'%`%/_A$M!_Z!L7YM_C1_PB6@_P#0-B_-O\\:VZ*`,3_A$M!_Z\nM!L7YM_C3H_"NAQ2+(FG1*RD,#D\\$?C6S10`4444`%%%%`!1110!YW\\3[PM/9\nMV2RJ54&1T&,@]`3^&:QO!>B)K-_-FYFMWMU$B/$,KY;_Q)=2)M*(?+\nM5E;(8#O7:?#6U:\'0I9V*E9Y25`ZC\'\'/Y4`)J\'ASQ\'JA4^QKG;\'PKK.C/,FCZPD=M(0=DL>XYQUQC`/T]!78T4`', u'\nM:[=OJ,^>`S\':!G(_KQTYKJH88X(EBAC2.-1A410`/H!3Z*`"BBB@`HHHH`X[\nMQ!X#@U&Y:ZL)5MI7.70CY#UR0!WZ5GV?PU/F\'[;?@ICCR5YS^->@T4`5-.TV\nMTTRW$%G`D2@`$J,%L=R>Y^M4]1T"#4-9L]2DFD62TQM1Q;BF2CCAD)\'8_TZ/+>Y;=LQTP/Y>E=#10\nM!GWNFO=W]K', u"M:B@#R]OAUK+,2;BR)/)_>-_P#$UN:-HOBO1K7[\nM+;76FM#NW`2%SCUQ\\M=I10`4444`%%%%`!1110`4444`%%%%`!1110`4444`\nM%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4\nM444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11\n- -10`4444`%%%%`'__V3\\_\n`\nend\n\n", u'\n', u'\n\n-----END PRIVACY-ENHANCED MESSAGE-----\n']